13 May, 2025 Comend and Odylia Partner to Advance Rare Disease Drug Development with Innovative Patient-Driven Platform
05 May, 2025 Odylia Therapeutics Announces New Pipeline Project: A Gene Replacement Therapy for NPHP1 Retinal Dystrophy
10 April, 2025 Odylia Therapeutics drives commitment to rare disease drug development through Rare Disease Day event
